H

Hansa Biopharma AB (publ)

164 employees

Hansa Biopharma is a biopharmaceutical company that develops immunomodulatory treatments for people living with rare immunological diseases.

Basic info

Industry

biotechnology research

Sectors

Biotechnology
In vitro diagnostics
Antibody glycosylation
Autoimmune disease
Biopharmaceuticals
Orphan drug
Rare diseases
Health Care
Clinical development
Sepsis
Immunomodulatory
Drug discovery
Kidney transplantation

Date founded

2007

Funding rounds raised

Total raised

$70M

from 1 investors over 1 rounds

H

Hansa Biopharma AB (publ) raised $70M on July 18, 2022

Investors: -

FAQ